|
|
|
|
LEADER |
08231nam a2200721 4500 |
001 |
ocn917551850 |
003 |
OCoLC |
005 |
20170124071335.8 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
150811s2015 enk ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d IDEBK
|d N$T
|d OCLCO
|d YDXCP
|d DG1
|d OCLCF
|d OCLCO
|d CDX
|d COO
|d CUS
|d OCLCQ
|d OCLCO
|d NLE
|d EBLCP
|d YDX
|d EMM
|d OCLCO
|d KSU
|d DG1
|d CCO
|d GrThAP
|
015 |
|
|
|a GBB613611
|2 bnb
|
019 |
|
|
|a 934935791
|a 958480687
|
020 |
|
|
|a 9781118674864
|q (electronic bk.)
|
020 |
|
|
|a 1118674863
|q (electronic bk.)
|
020 |
|
|
|a 9781118674826
|q (electronic bk.)
|
020 |
|
|
|a 1118674820
|q (electronic bk.)
|
020 |
|
|
|a 9781118674857
|q (electronic bk.)
|
020 |
|
|
|a 1118674855
|q (electronic bk.)
|
028 |
0 |
2 |
|a EB00623993
|b Recorded Books
|
029 |
1 |
|
|a GBVCP
|b 835780627
|
029 |
1 |
|
|a AU@
|b 000058391487
|
035 |
|
|
|a (OCoLC)917551850
|z (OCoLC)934935791
|z (OCoLC)958480687
|
037 |
|
|
|a 9781118674857
|b Wiley
|
050 |
|
4 |
|a RC280.B5
|b .B53 2015
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
4 |
|a 616.99/462
|2 23
|
049 |
|
|
|a MAIN
|
245 |
0 |
0 |
|a Bladder cancer :
|b diagnosis and clinical management /
|c edited by Seth P. Lerner, Mark P. Schoenberg, Cora N. Sternberg.
|
264 |
|
1 |
|a Chichester, West Sussex :
|b Wiley Blackwell,
|c 2015.
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
588 |
0 |
|
|a Online resource; title from PDF title page (EBSCO, viewed August 14, 2015).
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
0 |
|g Part 1.
|t Diagnosis and treatment of non-muscle-invasive bladder cancer.
|g 1.
|t Pathology /
|r Hikmat Al-Ahmadie, Donna E. Hansel ;
|g 2.
|t Risk stratification of high-grade Ta, CIS, and TI urothelial carcinoma of the bladder /
|r Tobias Klatte, Fred Witjes, Gary Steinberg, Shahrokh F. Shariat ;
|g 3.
|t Utility of urine biomarkers /
|r Derya Tilki, Alexandre R. Zlotta ;
|g 4.
|t Novel endoscopic techniques for the detection of bladder cancer /
|r Ayman Soubra, Joseph C. Liao, Badrinath Konety ;
|g 5.
|t Transurethral resection of bladder tumors /
|r Jen-Jane Liu, Mark P. Schoenberg ;
|g 6.
|t Intravesical chemotherapy /
|r Levent N. Türrkeri, M. Guillaume Wientjes, Jessie L.S. Au ;
|g 7.
|t Intravesical immunotherapy /
|r Nilay M. Gandhi, Laura A. Bertrand, Donald L. Lamm, Michael A. O'Donnell ;
|g 8.
|t HGT1 bladder cancer: Diagnosis and treatment /
|r J.M. Gaya, J. Palou, Edward M. Messing ;
|g 9.
|t What to do when bacillus Calmette-Guerin fails /
|r Massimiliano Spaliviero, Guido Dalbagni, Matthew Nielsen --
|g Part 2.
|t T2-4.
|g 10.
|t Selection and perioperative management of patients undergoing radical cystectomy and urinary reconstruction /
|r Robert. S. Svatek, Alon Z. Weizer ;
|g 11.
|t Radical cystectomy: Techniques and outcomes /
|r Siamak Daneshmand, Seth P. Lerner ;
|g 12.
|t Cystectomy in the female patient /
|r Ryan Werntz, Gerogios Gakis, Theresa Koppie, Arnulf Stenzl ;
|g 13.
|t Laparoscopic/robotic radical cystectomy and urinary diversion: Outcomes /
|r Kristina Wittig, Kevin Chan, Mark Kawachi, Timothy G. Wilson ;
|g 14.
|t Robotic assisted radical cystectomy and urinary diversion: Clinical trials /
|r George J.S. Kallingal, Angela B. Smith, Raj S. Pruthi, Dipen J. Parekh ;
|g 15.
|t Role of extended lymphadenectomy /
|r Eugene K. Cha, George N. Thalmann, Bernard H. Bochner ;
|g 16.
|t Management of the urethra in the cystectomy patient /
|r Kamal S. Pohar, Norm D. Smith ;
|g 17.
|t The role of radical cystectomy in patients with unresectable or regionally metastatic urothelial carcinoma of the bladder /
|r Scott Delacroix, Jr., Nathan Lawrentschuk, Ashish M. Kamat --
|g Part 3.
|t Primary bladder-sparing therapy.
|g 18.
|t Radical transurethral resection /
|r Eduardo Solsona, Harry W. Herr ;
|g 19.
|t Partial cystectomy /
|r Ahmed Haddad, Yair Lotan, Arthur I. Sagalowsky ;
|g 20.
|t Integrating chemotherapy and radiotherapy for bladder cancer /
|r Lior Z. Braunstein, William U. Shipley, Nicholas D. James, Andrea B. Apolo, Jason A. Efstathiou --
|g Part 4.
|t Urinary tract reconstruction.
|g 21.
|t Orthotopic neobladder /
|r Eila C. Skinner ;
|g 22.
|t Continent cutaneous diversion /
|r Andreas Neisius, Joachim W. Thüroff ;
|g 23.
|t Non-continent urinary diversion /
|r Michael Rink, Fredrik Liedberg, Margit Fisch --
|g Part 5.
|t Treatment of regionally advanced and metastatic bladder cancer.
|g 24.
|t Molecular determinants of chemotherapy response /
|r Matthew I. Milowsky, Peter H. O'Donnell, Thomas W. Flaig, Dan Theodorescu ;
|g 25.
|t Neoadjuvant chemotherapy in the treatment of muscle-invasive bladder cancer /
|r David I. Quinn, Cora N. Sternberg ;
|g 26.
|t Adjuvant chemotherapy for invasive bladder cancer /
|r André P. Fay, Jeffrey J. Leow, Joaquim Bellmunt ;
|g 27.
|t Treatment of metastatic bladder cancer /
|r Gopa Iyer, Fabio Calabró, Dean F. Bajorin ;
|g 28.
|t Treatment of poor risk patients /
|r Maria de Santis, Matthew D. Galsky --
|g Part 6.
|t Genomics and the current status of urothelial cancer.
|g 29.
|t Molecular events in muscle-invasive bladder cancer development /
|r Jonathan Rosenberg, William Y. Kim, Jaegil Kim, David J. Kwiatkowski ;
|g 30.
|t Cancer stem cells and intrinsic subtypes in bladder cancer /
|r Keith Syson Chan, David J. McConkey ;
|g 31.
|t Multi-targeted agents in the treatment of urothelial carcinoma /
|r Noah M. Hahn, Colin P.N. Dinney, Guru Sonpavde --
|g Part 7.
|t Optimizing healthcare delivery.
|g 32.
|t Patient navigation and cancer navigator programs /
|r Scott M. Gilbert, Michael Porter ;
|g 33.
|t Impact of health services on compliance and outcomes /
|r Heather Honoré Goltz, Marc A. Kowalkowski, G. John Chen, David M. Latini ;
|g 34.
|t Quality of life and survivorship /
|r Nihal E. Mohamed, Cheryl T. Lee ;
|g 35.
|t Bladder cancer: Healthcare delivery and third party payers /
|r Seth A. Strope, John L. Gore ;
|g 36.
|t Bladder cancer patient advocacy: Creating partnerships to advance patient care, research, and clinical trials /
|r Diane Zipursky Quale, Rick Bangs.
|
520 |
|
|
|a Bladder Cancer: Diagnosis and Clinical Management is a 100% clinically-focused guide to bladder cancer, providing practical, modern and evidence-based guidance to the latest in diagnosis and management of the condition. It differs from other books in its complete clinical focus as opposed to a heavy analysis of pathogenesis or basic science. As a result, practicing urologists and oncologists in the clinical setting will find it an essential resource to consult. In addition to the latest in diagnostic tools and imaging methods, core focus is on the management of each form of cancer at its various stages. Both drug therapies and the range of surgical options are covered, ensuring that this is the perfect tool for clinicians to consult when considering which type of management program is appropriate for each individual patient. A key addition is the final section dedicated to optimizing health care delivery, featuring chapters on highly topical issues such as quality of life, patient advocacy and surgical education.
|
506 |
|
|
|a Owing to Legal Deposit regulations this resource may only be accessed from within National Library of Scotland. For more information contact enquiries@nls.uk.
|5 StEdNL
|
650 |
|
0 |
|a Bladder
|x Cancer.
|
650 |
|
0 |
|a Bladder
|x Cancer
|x Diagnosis.
|
650 |
|
0 |
|a Bladder
|x Cancer
|x Treatment.
|
650 |
1 |
2 |
|a Urinary Bladder Neoplasms
|x diagnosis.
|
650 |
1 |
2 |
|a Urinary Bladder Neoplasms
|x therapy.
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Bladder
|x Cancer.
|2 fast
|0 (OCoLC)fst00834067
|
650 |
|
7 |
|a Bladder
|x Cancer
|x Diagnosis.
|2 fast
|0 (OCoLC)fst01767130
|
650 |
|
7 |
|a Bladder
|x Cancer
|x Treatment.
|2 fast
|0 (OCoLC)fst00834069
|
655 |
|
4 |
|a Electronic books.
|
700 |
1 |
|
|a Lerner, Seth P.,
|e editor.
|
700 |
1 |
|
|a Schoenberg, Mark P.,
|e editor.
|
700 |
1 |
|
|a Sternberg, Cora N.,
|e editor.
|
856 |
4 |
0 |
|u https://doi.org/10.1002/9781118674826
|z Full Text via HEAL-Link
|
994 |
|
|
|a 92
|b DG1
|